Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The objective of the present study was to obtain information about the safety, tolerability and pharmacokinetics of BIIR 561 CL after continuous intravenous administration of two increasing doses in healthy elderly volunteers, following the infusion schema of a loading dose (1 hour) and a maintenance dose (5 hours)
Epistemonikos ID: 9d31ffaee544d7eb3f45104b473d7ef77a123c8a
First added on: May 12, 2024